Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases (93.083)
Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases (Assistance Listing 93.083) is run by the Centers for Disease Control and Prevention, part of the Department of Health and Human Services. It awarded $58.2 million in 30 grants from fiscal 2021 to 2025, about $1.9 million per award on average. 2 funding opportunities are open or forecast now.
The typical award was $275,241. Half of the 30 awards fell between $243,000 and $450,000, and they ranged from $33,002 to $40.4 million.
- Awarded, FY 2021 to 2025$58.2 million
- Grant awards30
- Typical award$275,241
- Awarded in FY 2025$3.4 million
- Size rank984 of 1824
- Type of assistanceProject grants (cooperative agreements)
Key findings
- Annual funding fell from $26.4 million in fiscal 2021 to $3.4 million in fiscal 2025.
- It is the 984th largest of 1,824 federal grant programs by five-year awards.
- The 20 largest recipients received 99% of the money.
- Awards went to recipients in 15 states and territories.
What the program funds
The purpose of this program is to strengthen capacity to prevent disease, disability, and death through immunization and control of respiratory and related diseases. The specific objectives may include, but are not limited to: 1. Increase the population of children and adults who are free from respiratory infectious disease complications. 2. Strengthen local, state, and national capacity for the early detection, investigation, response and control of respiratory infections in order to accelerate early recognition of respiratory threats and to mitigate the impact of their spread. 3. Control the rise in antimicrobial resistant respiratory infections in the community. 4. Strengthen prevention and control of respiratory infections in institutional settings, such as health care facilities and workplaces. 5. Reduce mortality from pneumonia and other severe respiratory infections. 6. Strengthen capacity for early detection, investigation, response, and control of respiratory infectious threats.
Open opportunities
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- Expanded Surveillance for Pediatric Infectious Diseases
Rules from the program listing
Who can apply
Dependent on the NOFO, eligibility may range from open competition, limited competition, single-source, domestic and/or international in accordance with the authorizing language.
What the money can and cannot pay for
Funds may be used towards prevention and control of disease, disability, and/or death through immunization against respiratory and related diseases. Restrictions to funding are designated in the individual Notice of Funding Opportunity (NOFO) and, for those awarded, in the Notice of Award (NoA).
Matching requirements
Statutory Formula: Title NCIRD, Part Will follow the guidance of the CFR, Subpart Will follow the guidance of the CFR,Public Law Will follow the guidance of the CFR.Will follow the guidance of the CFRMatching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Deadlines
Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.
Award range and average, in the agency's words
$500,000 - $2,000,000, Average $1,000,000
Funding history and past recipients
From fiscal 2021 to 2025, Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases (93.083) awarded$58.2 million across 30 grant awards, an average of $1.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Council of Medical Specia | Illinois | 1 | $40.4 million |
| Post-Acute and Long-Term Care Medical Association, Inc. | Maryland | 1 | $7.1 million |
| National Health Laboratory Service | 1 | $3.1 million | |
| All India Institute of Medical Sciences | 1 | $1.0 million | |
| American Cancer Society, Inc | Georgia | 2 | $900,000 |
| State of Alaska Department of Health | Alaska | 1 | $785,760 |
| Chinese Center for Disease Control and Prevention | 1 | $773,500 | |
| American Academy of Pediatrics | Illinois | 1 | $500,000 |
| Triangle Biotechnology, Inc | North Carolina | 1 | $300,000 |
| Florida Department of Health | Florida | 1 | $300,000 |
| New Jersey Department of Health | New Jersey | 1 | $300,000 |
| HDT Bio Corp | Washington | 1 | $299,984 |
| Eitr Biologics, Inc. | California | 1 | $299,794 |
| Electronucleics Inc | California | 1 | $275,760 |
| Dotquant LLC | Washington | 1 | $275,482 |
| Vaccinate Your Family, Inc | Connecticut | 1 | $275,000 |
| Virongy Biosciences Inc | Virginia | 1 | $273,181 |
| Carogen Corp | Connecticut | 1 | $263,991 |
| Serplus Technology, LLC | California | 1 | $259,613 |
| Sunomix Therapeutics | California | 1 | $252,010 |
Who usually wins
Nonprofits received 84% of the money, small businesses 6.4% and state and local governments 2.7%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Nonprofits | 7 | $48.8 million | 84% |
| Other | 3 | $4.2 million | 7.2% |
| Small businesses | 14 | $3.7 million | 6.4% |
| State and local governments | 6 | $1.6 million | 2.7% |
By state
4 states have a page for this program: those that received at least $1 million or 10 awards. They are Illinois, Maryland, California and Washington.
| State | Awards | Amount |
|---|---|---|
| Illinois | 2 | $40.9 million |
| Maryland | 2 | $7.2 million |
| California | 5 | $1.3 million |
| Washington | 4 | $1.1 million |
| Georgia | 2 | $900,000 |
| Alaska | 1 | $785,760 |
| Connecticut | 2 | $538,991 |
| Florida | 1 | $300,000 |
| New Jersey | 1 | $300,000 |
| North Carolina | 1 | $278,857 |
| Virginia | 1 | $273,181 |
| Indiana | 1 | $243,000 |
| Guam | 1 | $121,040 |
| Northern Mariana Islands | 1 | $50,608 |
| American Samoa | 1 | $33,002 |